Skip to content

A prospective randomized controlled clinical study of Intrasite vancomycin powder for the prevention of surgical site infection in instrumented spine surgery

A prospective randomized controlled clinical study of Intrasite vancomycin powder for the prevention of surgical site infection in instrumented spine surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011052
Enrollment
Unknown
Registered
2017-04-04
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SSI of spine surgery

Interventions

A:Vancomycin powder topical application of incision

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients undergoing various instrumented spine surgery; 2. good compliance and voluntary participation in clinical trials, signed informed consent or informed consent will be signed by legal representative.

Exclusion criteria

Exclusion criteria: (1) the current or most recent months of infection; (2) the current or most recent months use systemic antibiotics in patients; (3) the current or most recent years using immune inhibitors or immune modulators of patients; (4) diagnosed immunodeficiency disease patients; (5) as the surgical indications for infection of patients; (6) Patients with severe liver, renal insufficiency; (7) of vancomycin allergies; (8) pregnant women and nursing mothers; (9) other researchers think that doesn't fit.

Design outcomes

Primary

MeasureTime frame
The rate of Surgical site infection;

Countries

China

Contacts

Public ContactRen Kai

Shenzhen Second People's Hospital

renkiss@126.com+86 18922801119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026